Eli Lilly News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

14.06.17	Patented Biotechnology Formulations Resulting in New Generation of Animal Healthcare Medications and Treatments (PR Newswire)
14.06.17	Patented Biotechnology Formulations Resulting in New Generation of Animal Healthcare Medications and Treatments (PR Newswire)
14.06.17	Lilly to Present New Data on Olumiant® (baricitinib) in Rheumatoid Arthritis and Taltz® (ixekizumab) in Psoriatic Arthritis at the Annual European Congress of Rheumatology (EULAR 2017) (PR Newswire)
13.06.17	Jardiance® (empagliflozin) analysis reinforces established safety profile (PR Newswire)
12.06.17	Elanco Releases First-Ever Corporate Social Responsibility Impact Report (PR Newswire)
12.06.17	Boehringer, Eli Lilly To Conduct New Trial Investigating Jardiance Tablets (RTTNews)
12.06.17	Jardiance® (empagliflozin) tablets to be studied in chronic kidney disease (PR Newswire)
10.06.17	Lilly's Galcanezumab Significantly Reduces Number of Migraine Headache Days for Patients with Migraine: New Results Presented at AHS (PR Newswire)
09.06.17	IDF, in partnership with Lilly, announces second phase of BRIDGES programme funding for translational research in diabetes with focus on secondary prevention (PR Newswire)
08.06.17	Lilly to Present Late-Breaking Data for Galcanezumab and Lasmiditan at the American Headache Society Annual Scientific Meeting (PR Newswire)
08.06.17	Lilly Announces Webcast to Discuss Pain Management Portfolio (PR Newswire)
08.06.17	Lilly Announces Strategic Collaboration with KeyBioscience AG (PR Newswire)
07.06.17	News Alert: Blink Health To Give Away $10 Million Worth Of Free Diabetes Medications To Help People Afford Treatment (PR Newswire)
07.06.17	Blink Health Commits To Give Away $10 Million Worth Of Free Diabetes Medications To Help People Afford Treatment (PR Newswire)
03.06.17	Lilly Builds Upon Body of Data for Abemaciclib with Phase 3 MONARCH 2 Data Demonstrating Superior Progression-Free Survival in Advanced Breast Cancer (PR Newswire)
01.06.17	Boehringer Ingelheim and Lilly Diabetes Alliance to Present 33 Abstracts at the American Diabetes Association's 77th Scientific Sessions® (PR Newswire)
01.06.17	Eli Lilly CFO Derica Rice To Retire By End Of 2017 - Quick Facts (RTTNews)
01.06.17	Derica Rice to Retire as Lilly Chief Financial Officer (PR Newswire)
01.06.17	Drug Makers Stocks on Investors' Radar -- AstraZeneca, Bristol-Myers Squibb, Eli Lilly, and Sanofi (PR Newswire)
31.05.17	Lilly to Participate in Goldman Sachs Global Healthcare Conference (PR Newswire)
31.05.17	Lilly Says Phase 3 RANGE Urothelial Cancer Trial Of CYRAMZA Met Primary Endpoint (RTTNews)
31.05.17	Lilly Announces Phase 3 RANGE Urothelial Cancer Trial of CYRAMZA® (ramucirumab) Met Primary Endpoint, Improving Progression-Free Survival (PR Newswire)
31.05.17	ALBO Spikes, GLYC Abuzz, FDA Approves 1st Generic Strattera For ADHD (RTTNews)
24.05.17	Elanco Animal Health Works to Bring Products to Small Holder Farmers, Increasing Food Security in East Africa (PR Newswire)
17.05.17	Lilly to Present Results from Pivotal Breast Cancer Study of Abemaciclib and New Portfolio Data at ASCO 2017 (PR Newswire)
16.05.17	Actress Angela Bassett joins For Your SweetHeart™ to urge people with diabetes to know their heart disease risk -- in honor of her mom (PR Newswire)
12.05.17	MÄRKTE USA/Zweifel an Konsumfreude dämpfen Stimmung an Wall Street (Dow Jones)
12.05.17	MÄRKTE USA/Zweifel an Konsumfreude dürften Wall Street belasten (Dow Jones)
12.05.17	Lilly: Galcanezumab For Migraine Met Primary Endpoint In Three Phase 3 Trials (RTTNews)
12.05.17	Lilly Announces Positive Results for Three Phase 3 Studies of Galcanezumab for the Prevention of Episodic and Chronic Migraine (PR Newswire)
10.05.17	Lilly to Participate in Bernstein Strategic Decisions Conference (PR Newswire)
10.05.17	Leigh Ann Pusey Joins Lilly as Senior Vice President of Corporate Affairs and Communications (PR Newswire)
03.05.17	Lilly to Participate in UBS Global Healthcare Conference (PR Newswire)
02.05.17	Lilly Announces Webcast to Discuss Oncology Pipeline (PR Newswire)
01.05.17	Lilly Declares Second-Quarter 2017 Dividend (PR Newswire)
26.04.17	The global car rental industry is expected to reach $99.6 billion by 2022 (PR Newswire)
25.04.17	Autism Awareness Puts Spotlight on Development of Innovative Therapies and Treatments for Youth Mental Disorders (PR Newswire)
25.04.17	Autism Awareness Puts Spotlight on Development of Innovative Therapies and Treatments for Youth Mental Disorders (PR Newswire)
25.04.17	Neue Medikamente kurbeln bei Eli Lilly Umsatz an (AWP) Der US-Pharmakonzern Eli Lilly hat im ersten Quartal von einer guten Nachfrage nach seinen neuen Medikamenten profitiert.» mehr
25.04.17	Lilly Q1 Results Top Estimates; Cuts 2017 EPS View (RTTNews)
25.04.17	Eli Lilly And Co. Announces 18% Increase In Q1 Profit (RTTNews)
25.04.17	Lilly Reports First-Quarter 2017 Results (PR Newswire)
24.04.17	Lilly :Phase 3 MONARCH 3 Breast Cancer Study Of Abemaciclib Shows Superior PFS (RTTNews)
24.04.17	Lilly Announces Phase 3 MONARCH 3 Breast Cancer Study of Abemaciclib Demonstrated Superior Progression-Free Survival at Interim Analysis (PR Newswire)
24.04.17	Drug Makers Stocks Under Scanner -- Bristol-Myers, AstraZeneca, Eli Lilly, and Immune Pharma (PR Newswire)
20.04.17	Lilly to Present Data for Galcanezumab for the Prevention of Migraine at the American Academy of Neurology (AAN) Annual Meeting (PR Newswire)
19.04.17	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Eli Lilly and Company - LLY (PR Newswire)
17.04.17	MÄRKTE USA/Berichtssaison verdrängt geopolitische -2- (Dow Jones)
17.04.17	MÄRKTE USA/Berichtssaison verdrängt geopolitische Sorgen an der Wall Street (Dow Jones)
17.04.17	MÄRKTE USA/Berichtssaison verdrängt geopolitische Sorgen an der Wall Street (Dow Jones)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

ABB	52.12	0.46 %	K V
Part Grp Hldg	1’272.50	0.43 %	K V
Alcon	76.50	0.24 %	K V
Sonova Hldg	298.00	0.24 %	K V
Holcim	89.04	0.20 %	K V
Swisscom	503.00	-0.79 %	K V
Sika	223.90	-1.02 %	K V
Swiss Re	130.25	-1.29 %	K V
Givaudan	4’006.00	-1.35 %	K V
Nestle	73.96	-1.68 %	K V

mehr

12:26		Börse Europa in Grün: Euro STOXX 50 steigt mittags
12:26		Börse Zürich: SMI präsentiert sich leichter
09:29		Verluste in Europa: Euro STOXX 50 beginnt die Mittwochssitzung im Minus
09:29		Verluste in Zürich: SMI beginnt Mittwochshandel im Minus
09:29		Optimismus in Frankfurt: DAX zum Handelsstart fester
09:29		Pluszeichen in Frankfurt: Anleger lassen LUS-DAX zum Start steigen
17.12.24		Schwache Performance in New York: S&P 500 beendet den Handel im Minus
17.12.24		Pfizer-Aktie unverändert: Umsatz auf Vorjahreshöhe für 2025 geplant

12:26

Börse Europa in Grün: Euro STOXX 50 steigt mittags

12:26

Börse Zürich: SMI präsentiert sich leichter

09:29

Verluste in Europa: Euro STOXX 50 beginnt die Mittwochssitzung im Minus

09:29

Verluste in Zürich: SMI beginnt Mittwochshandel im Minus

09:29

Optimismus in Frankfurt: DAX zum Handelsstart fester

09:29

Pluszeichen in Frankfurt: Anleger lassen LUS-DAX zum Start steigen